enkephalin, leucine and Amphetamine-Related Disorders

enkephalin, leucine has been researched along with Amphetamine-Related Disorders in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (20.00)18.2507
2000's4 (80.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Belkaï, E; Marie-Claire, C; Noble, F; Scherrmann, JM1
McGinty, JF; Shi, X1
Harano, M; Inada, T; Iwata, N; Iyo, M; Kishimoto, M; Komiyama, T; Kuroda, S; Morio, A; Morita, Y; Nomura, A; Otani, K; Ozaki, N; Sekine, Y; Sora, I; Tanaka, Y; Ujike, H; Yamada, M1
Blake, H; Comings, DE; Dietz, G; Gade-Andavolu, R; Johnson, P; Legro, RS; MacMurray, JP; Saucier, G; Verde, R1
Hurd, YL; Peckys, D1

Other Studies

5 other study(ies) available for enkephalin, leucine and Amphetamine-Related Disorders

ArticleYear
Modulation of MDMA-induced behavioral and transcriptional effects by the delta opioid antagonist naltrindole in mice.
    Addiction biology, 2009, Volume: 14, Issue:3

    Topics: Amphetamine-Related Disorders; Animals; Behavior, Animal; Brain; Choice Behavior; Conditioning, Classical; Enkephalins; Gene Expression; Hallucinogens; Mice; Motor Activity; N-Methyl-3,4-methylenedioxyamphetamine; Naltrexone; Narcotic Antagonists; Pro-Opiomelanocortin; Protein Precursors; Receptors, Opioid, delta; RNA, Messenger; Social Environment; Transcription, Genetic

2009
Extracellular signal-regulated mitogen-activated protein kinase inhibitors decrease amphetamine-induced behavior and neuropeptide gene expression in the striatum.
    Neuroscience, 2006, Volume: 138, Issue:4

    Topics: Aminoacetonitrile; Amphetamine; Amphetamine-Related Disorders; Animals; Butadienes; Corpus Striatum; Disease Models, Animal; Dynorphins; Enkephalins; Enzyme Inhibitors; Extracellular Signal-Regulated MAP Kinases; Gene Expression Regulation; Male; MAP Kinase Signaling System; Motor Activity; Neuropeptides; Nitriles; Phosphorylation; Protein Precursors; Rats; Rats, Sprague-Dawley; RNA, Messenger; Up-Regulation

2006
Genetic variant of prodynorphin gene is risk factor for methamphetamine dependence.
    Neuroscience letters, 2006, May-29, Volume: 400, Issue:1-2

    Topics: Adult; Amphetamine-Related Disorders; Confidence Intervals; Enkephalins; Female; Gene Frequency; Genetic Predisposition to Disease; Genotype; Humans; Male; Middle Aged; Odds Ratio; Polymorphism, Genetic; Promoter Regions, Genetic; Protein Precursors; Repetitive Sequences, Nucleic Acid; Risk Factors

2006
The proenkephalin gene (PENK) and opioid dependence.
    Neuroreport, 1999, Apr-06, Volume: 10, Issue:5

    Topics: Adult; Alcohol-Related Disorders; Alleles; Amphetamine-Related Disorders; Cocaine-Related Disorders; Dinucleotide Repeats; Enkephalins; Female; Gene Frequency; Heroin Dependence; Humans; Male; Protein Precursors; Substance-Related Disorders; White People

1999
Prodynorphin and kappa opioid receptor mRNA expression in the cingulate and prefrontal cortices of subjects diagnosed with schizophrenia or affective disorders.
    Brain research bulletin, 2001, Jul-15, Volume: 55, Issue:5

    Topics: Adult; Age Factors; Amphetamine-Related Disorders; Bipolar Disorder; Depressive Disorder, Major; Enkephalins; Female; Functional Laterality; Humans; In Situ Hybridization; Male; Marijuana Abuse; Middle Aged; Protein Precursors; Receptors, Opioid, kappa; RNA, Messenger; Schizophrenia; Sex Factors; Suicide

2001